Abstract:Inflammatory caspases (caspase-1, -4, -5 and -11) are critical for innate defences. Caspase-1 is activated by ligands of various canonical inflammasomes, and caspase-4, -5 and -11 directly recognize bacterial lipopolysaccharide, both of which trigger pyroptosis. Despite the crucial role in immunity and endotoxic shock, the mechanism for pyroptosis induction by inflammatory caspases is unknown. Here we identify gasdermin D (Gsdmd) by genome-wide clustered regularly interspaced palindromic repeat (CRISPR)-Cas9 nuclease screens of caspase-11- and caspase-1-mediated pyroptosis in mouse bone marrow macrophages. GSDMD-deficient cells resisted the induction of pyroptosis by cytosolic lipopolysaccharide and known canonical inflammasome ligands. Interleukin-1β release was also diminished in Gsdmd−/− cells, despite intact processing by caspase-1. Caspase-1 and caspase-4/5/11 specifically cleaved the linker between the amino-terminal gasdermin-N and carboxy-terminal gasdermin-C domains in GSDMD, which was required and sufficient for pyroptosis. The cleavage released the intramolecular inhibition on the gasdermin-N domain that showed intrinsic pyroptosis-inducing activity. Other gasdermin family members were not cleaved by inflammatory caspases but shared the autoinhibition; gain-of-function mutations in Gsdma3 that cause alopecia and skin defects disrupted the autoinhibition, allowing its gasdermin-N domain to trigger pyroptosis. These findings offer insight into inflammasome-mediated immunity/diseases and also change our understanding of pyroptosis and programmed necrosis.

IRF2 transcriptionally induces GSDMD expression for pyroptosis

Research Progresses of Molecular Mechanism of Pyroptosis and Its Related Diseases

Transcription factor Sp1 transcriptionally enhances GSDME expression for pyroptosis

Gasdermin D in pyroptosis

Pyroptosis, inflammasome, and gasdermins in tumor immunity

Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway

Gasdermins: a dual role in pyroptosis and tumor immunity

Gasdermin-mediated Pyroptosis Confers Anticancer Immunity

Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death

Inverse regulation of GSDMD and GSDME gene expression during LPS-induced pyroptosis in RAW264.7 macrophage cells

Downstream of gasdermin D cleavage, a Ragulator-Rag-mTORC1 pathway promotes pore formation and pyroptosis

The gasdermin family: emerging therapeutic targets in diseases

Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors

Pyroptosis: a double-edged sword in lung cancer and other respiratory diseases

Gasdermin-E Mediated Pyroptosis—A Novel Mechanism Regulating Migration, Invasion and Release of Inflammatory Cytokines in Rheumatoid Arthritis Fibroblast-like Synoviocytes

Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death

Gasdermin D:The killer protein performs cell pyroptosis

Palmitoylation of gasdermin D directs its membrane translocation and pore formation in pyroptosis

Crosstalk of HDAC4, PP1, and GSDMD in controlling pyroptosis

Gasdermin E is required for induction of pyroptosis and severe disease during enterovirus 71 infection

Full-length GSDME mediates pyroptosis independent from cleavage